Publications

← Return to the complete list of publications

AML with EVI1 rearrangements are characterized by SF3B1 and IKZF1 mutations and distinct expression of MECOM isoforms.

Lavallée VP, Boivin I, Armstrong RN, Lemieux S, Gendron P, Hebert J, Sauvageau G

Institute for Research in Immunology and Cancer, l'Université de Montréal, Montréal, Quebec, Canada; Hôpital Maisonneuve-Rosemont, Montréal, Quebec, Canada.

Exp. Hematol. 2014;42(8 Suppl):S44.

Pubmed ID: 25106277

Follow IRIC

Logo UdeM